coverage of the 2005 BioTech Convention in Philadelphia. This is The MARCH of DEATH. 1 dead camera 1 dead cop 1 dead constitution more BioTech Video & Links fluxrostrum.blogspot.com 2007 BioTech Convention BOSTON May 6 – 9th www.biodev.org www.bio2007.org The “suits” are a special division of Philly Police Officers called Civil Affairs Officers. I asked one of them Qoute: “What’s the deal with the arms bands?” “I’m the Police” “Yeah, I figured that out; but what’s the difference between you guys and the guys in blie uniforms?” “We’re here to specifically assure that you guys get your 1st ammendment rights.” “Oh… cool..” It seems odd that they were the most out of control, quick to violence cops I’ve seen yet. … it’s unfortunate, because one of them had a heart attack and died in that melee… it’s sad.. and it was completely unnecessary and completely their own damn fault for charging into a passive unsuspecting crowd kicking and punching. the video is so completly jumbled at that point becuase we were being tossed around… The second angle of the melee is from the camera that was grabbed and tossed to the ground by a cop. I was not using it at the time; but it was my 1st camera and had given many years service to the cause of the people. D8-1′s Final image was in fact the flashing (don’t know how) half skull you see at the end of the video… them it went blue.
Research and Markets: Pharmaceutical Industry Dynamics 2010: Licensing Opportunities: Rheumatology
DUBLIN—-Research and Markets has announced the addition of Decision Resources, Inc.’s new report “Pharmaceutical Industry Dynamics 2010: Licensing Opportunities: Rheumatology” to their offering.
Pharmaceutical, Healthcare & Life Sciences
The recently enacted health care reform legislation (H.R. 3590) includes a generous new tax credit that could benefit biotech firms and other health companies with fewer than 250 employees.
The explosion of innovations in pharmaceuticals and biotechnology has arguably made these industries the hottest areas in patent law.
PLI-s Pharmaceutical and Biotech Patent Law fully answers the crucial need for a clear and comprehensive guide to these exciting fields. Written by one of the country-s foremost patent law groups, this uniquely accessible reference provides you with the legal, scientific, and technical information you need to help clients obtain, defend, and challenge the validity of patents.
Readable enough for non-lawyers and non-scientists, Pharmaceutical and Biotech Patent Law shows you how to craft rock-solid patent applications for these inventions; partner with the government to bring patented inventions quickly to the marketplace; invalidate competitors- patents by proving they fail to meet key requirements; protect against various forms of patent infringement; and successfully rebut charges that your clients are infringers. Included are detailed checklists that help you resolve especially thorny patent problems.
Updated at least once a year, Pharmaceutical and Biotech Patent Law is a necessary guide for patent practitioners and other intellectual property attorneys, as well as legal counsel, executives, managers, and scientists in pharmaceutical and biotech firms.
Founded in 1933, Practising Law Institute (Practicing Law Institute, PLI) is the nation-s foremost provider of continuing legal education. PLI is a leading publisher of authoritative legal references and other information resources and offers more than 300 live and electronic programs nationally.
About the Authors
The Patent Group of Kaye Scholer LLP has been honored by The National Law Journal for its -exemplary, cutting-edge defense work- and has been called -the premier patent and biotech litigation group in the nation- by Vault Guide to the Top 100 Law Firms.
Digital showcase produced by UK Trade & Investment, promoting the UK’s expertise in Biotechnology and Pharmaceuticals. For more information on UK Trade & Investment and its services please visit www.uktradeinvest.gov.uk
Product Description Business Development in the Biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate take-overs are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects.The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin’s highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.
Product Description A great way to jump-start your career in pharmaceutical and biotechnology sales!
“Be brief, be bright, be gone” is the philosophy that launched David Currier to a successful career as a pharmaceutical sales representative. Simply stated, this approach encourages aspiring sales professionals to:
Be brief—Keep your sales presentations short and to the point.
Be bright—Understand your product and its clinical context.
Be gone—Respect your customer’s time.
But that is only one piece of advice an aspiring representative should retain from this book. This book also covers:
Pros and cons of a career in pharma/biotech sales
How to land a job with a major pharma/biotech company
Getting to know your customers (physicians and hospitals)
…and lots more, including 10 key tips that help ensure long-term career success.
This is the book that top pharmaceutical and biotech sales trainers have asked for!
“I wish I read this book when I got started. It is easily the best book I have seen on the subject.”—Ellen F. Simes, Springfield, MA, Pharma/biotech trainer
“Anyone even thinking about a career in the industry should read this book.”—Pam Marinko, Wilmington, NC, Pharma/biotech trainer
“Wow! Very well done. Some really good information for folks just starting out—and for veterans like me, too.”—JoAnne Skypeck, Holyoke, MA, Pharmaceutical sales representative
Product Description The Wood Mackenzie 2004 Executive’s Guide is an indispensable reference source for pharmaceutical and biotechnology executives. Now in its 17th edition, the Guide provides at-a-glance statistics and analysis of the WoodMac 50, Wood Mackenzie’s top 50 pharmaceutical and biotechnology companies.
For 2004, the Guide contains an expanded series of company summaries, a ranking table for the WoodMac 50 and an in-depth analysis of opportunities and critical issues for the pharmaceutical and biotechnology industries.
The 2004 edition includes:
-Five for ’05: Our top five issues and trends that life sciences companies will face in the coming year -Concise executive summaries for each of the WoodMac 50 -Wood Mackenzie’s Freshness Index, which measures the health of pipelines based on portfolio maturity -Company rankings for the WoodMac 50 -In-depth analysis of key therapeutic areas, companies and products in 2003
Product Description This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.
